Register for free
Recent Quotes
My Watchlist
Indicators
Business Insurance Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Bio-Rad Laboratories, Inc. Class A Common Stock (NY:BIO)

284.60 +42.65 (+17.63%)
Official Closing Price Updated: 7:00 PM EDT, Aug 1, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Bio-Rad Laboratories, Inc. Class A Common Stock

< Previous 1 2 3 Next >
Bio-Rad Reports Second-Quarter 2022 Financial Results
From Bio-Rad Laboratories, Inc.
Via Business Wire
Bio-Rad to Report Second Quarter 2022 Financial Results on Thursday, July 28, 2022
From Bio-Rad Laboratories, Inc.
Via Business Wire
Bio-Rad Publishes Corporate Sustainability Report
From Bio-Rad Laboratories, Inc.
Via Business Wire
Bio-Rad Reports First-Quarter 2022 Financial Results
From Bio-Rad Laboratories, Inc.
Via Business Wire
Bio-Rad to Report First-Quarter Financial Results, Thursday, April 28, 2022
From Bio-Rad Laboratories, Inc.
Via Business Wire
Bio-Rad Presents Growth Strategy and Acceleration of Financial Targets at Investor Day
From Bio-Rad Laboratories, Inc.
Via Business Wire
Bio-Rad Reports Fourth-Quarter and Full-Year 2021 Financial Results
From Bio-Rad Laboratories, Inc.
Via Business Wire
Bio-Rad to Host Investor Day on February 25
From Bio-Rad Laboratories, Inc.
Via Business Wire
Bio-Rad to Report Fourth-Quarter and Full-Year 2021 Financial Results, Thursday, February 10, 2022
From Bio-Rad Laboratories, Inc.
Via Business Wire
Bio-Rad to Participate in Fireside Chat During the 40th Annual J.P. Morgan Healthcare Conference on January 11
From Bio-Rad Laboratories, Inc.
Via Business Wire
Bio-Rad Appoints Simon May Executive Vice President and Life Science Group President
From Bio-Rad Laboratories, Inc.
Via Business Wire
Bio-Rad Reports Third-Quarter 2021 Financial Results
From Bio-Rad Laboratories, Inc.
Via Business Wire
Bio-Rad to Report Third-Quarter 2021 Financial Results, Thursday, October 28, 2021
From Bio-Rad Laboratories, Inc.
Via Business Wire
Bio-Rad to Participate in the 2021 Virtual Wells Fargo Healthcare Conference
From Bio-Rad Laboratories, Inc.
Via Business Wire
Bio-Rad Reports Second-Quarter 2021 Financial Results
From Bio-Rad Laboratories, Inc.
Via Business Wire
Bio-Rad and 10x Genomics Announce Settlement to Resolve Multiple Litigations
From Bio-Rad Laboratories, Inc.
Via Business Wire
Bio-Rad to Report Second-Quarter 2021 Financial Results, Thursday, July 29, 2021
From Bio-Rad Laboratories, Inc.
Via Business Wire
Bio-Rad Announces Partnership with Seegene for Molecular Diagnostic Testing Products
From Bio-Rad Laboratories, Inc.
Via Business Wire
Bio-Rad Launches Its PREvalence ddPCR SARS-CoV-2 Wastewater Quantification Kit for COVID-19 Wastewater Testing
From Bio-Rad Laboratories, Inc.
Via Business Wire
Bio-Rad to Participate at Jefferies Virtual Healthcare Conference
From Bio-Rad Laboratories, Inc.
Via Business Wire
Bio-Rad Reports First-Quarter 2021 Financial Results
From Bio-Rad Laboratories, Inc.
Via Business Wire
Bio-Rad to Report First-Quarter 2021 Financial Results, Thursday, April 29, 2021
From Bio-Rad Laboratories, Inc.
Via Business Wire
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.
Register for free

Information

Copyright 2024. BUSINESS INSURANCE HOLDINGS